The University of Texas at Austin
Austin, Texas, 78712, United States
Location status: Recruiting
NCT Number: NCT05802680
Inattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical hypometabolism has been hypothesized to contribute to inattentiveness in ADHD. Transcranial photobiomodulation (tPBM) is a safe and non-invasive modality for activation of the prefrontal cortex. tPBM in healthy adults has been shown to augment brain oxygenation, cognition, and mood. The cognition-enhancing effect of tPBM on sustained attention in adults with ADHD remains unstudied. The investigators will evaluate whether tPBM administration to adults with and without ADHD can improve their attention. Each participant will be screened for eighteen criteria based on the Diagnostic and Statistical Manual (DSM-IV, text revised), using the validated instrument Adult ADHD Self-Report Scale (ASRS-v1.1). Blinded participants will be randomized into (I) Active-tPBM or (II) Sham-tPBM groups. After undergoing an 8-minute administration of Sham or 1064 nm tPBM to the lateral and medial right prefrontal cortex, each participant will complete a 14-minute, computer-based Conner's continuous performance task-3 (CPT-3). The investigators will examine whether adults with and without ADHD who receive Active-tPBM improve in measures of inattention, impulsivity, sustained attention, or vigilance compared to the Sham-tPBM group. Cognitive assessments of attention like the CPT-3 may evaluate the efficacy of tPBM to increase cortical metabolism in healthy adults and individuals with conditions like ADHD. The investigators anticipate their investigation will be a starting point for more sophisticated studies that focus on the implications of tPBM on cognition.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Austin, Texas, 78712, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of Sham or 1064 (+/- 50) nanometers tPBM
Sham treatment
Time frame: Up to two months
Measure of inattention, impulsivity, sustained attention, vigilance
Time frame: Up to two months
Resting state and activational state using a memory task
Contact information is provided by the study sponsor or research team.
Francisco Gonzalez-Lima, PhD
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02287038
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Charleston, South Carolina, United States
View Trial DetailsNCT04631042
Anxiety Disorders, Attention Deficit Disorder with Hyperactivity
Bethesda, Maryland, United States
View Trial DetailsNCT06847165
Alcohol-Induced Disorders, Alcohol-Related Disorders
Los Angeles, California, United States
View Trial DetailsNCT05608434
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Bethesda, Maryland, United States
View Trial Details